Calendar
Contact Us
Meeting the Challenge Summit:
Diversity in Dermatology Clinical Trials
Friday and Saturday, June 10-11, 2022
The Mayflower Hotel, Autograph Collection
1127 Connecticut Ave., NW
Washington, D.C. 20036
Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials is a 1.5 day interactive meeting, with a networking welcome reception. The Summit convened key stakeholders across numerous disciplines and sectors to (1) define the scope of underrepresentation of minorities in dermatological studies, (2) identify the challenges that impede progress in creating a diverse cohort of study participants, (3) develop actionable recommendations to overcome barriers to progress, and (4) will disseminate meeting findings via a prominent publication. The summit included a welcome reception, industry panel, invited speakers, small and large group discussions, and more!
This is the first step of a continuum of efforts on behalf of SOCS to enhance the inclusion of under-represented minorities in clinical trials.
The Mayflower Hotel, Autograph Collection
1127 Connecticut Ave., NW
Washington, D.C. 20036
SOCS Room Block Extended to May 27th
Book your reservation at The Mayflower Hotel, Autograph Collection, and email your confirmation number to jayarzagoitia@skinofcolorsociety.org to be added to the SOCS room block and receive a discounted rate. Standard rooms, at regular rate, no pre-paid rooms only. Discounted rates begin at $219 USD + tax per night.
Note: 3rd party bookings will not be considered for the room block discount.
Complimentary breakfast will be served for all meeting attendees on Saturday, June 11, 2022 at 7:30AM ET.
Schedule Overview
Friday, June 10, 2022, 2:00 PM ET
Session 1: Understanding the Current Clinical Trials Landscape
6:00 PM ET | Networking Cocktail Reception
Saturday, June 11, 2022, 7:30 AM ET
7:30 AM ET | Breakfast
8:00 AM ET | Start Time
Invited Keynote Speaker & Q&A
Session 2: Breaking Down Barriers: Patient, Provider, Industry, Regulatory
Session 3: Effecting Change through a Diversity-Focused Strategy
David Lacks, Jr. is the grandson of Henrietta Lacks and the son of David “Sonny” Lacks. David has a degree in computer information systems and has traveled around the United States and Canada setting up computer systems and labs for companies and educational institutions. He also lends his talent to the Lacks family’s website. David is honored to serve on the National Institutes of Health panel, where he reviews proposals from researchers seeking to use the HeLa genome in their research.
Veronica Robinson is Henrietta Lacks’ great-granddaughter. Veronica is a patient rights advocate who speaks on Henrietta Lacks’ legacy, their family’s experience in biomedical research, impact on participation, and ethics in this modern era of precision medicine. Veronica travels the country sharing the Lacks Family’s efforts to control their medical history and rebuild trust with the medical community, subjects she was honored to speak about in a 2018 TEDx Talk. Working with the National Institutes of Health, Veronica serves as both an All of US Ambassador, advocating for access to precision medicine; and a Lacks Family Representative on the HeLa Genome Data Access Working Group. As a mentor for Baltimore City Public Schools, Veronica is committed to empowering the next generation. Inspired by Henrietta’s story, Veronica is currently studying at Baltimore City Community College to become a registered nurse to help make certain all people can access equitable and high-quality health care.
FRIDAY, JUNE 10, 2022
| Start (EDT) | End (EDT) | Session Details |
|---|---|---|
| 12:00 PM | Registration / Check-in | |
| 1:55 PM | 2:00 PM | Welcome and Introduction |
| Valerie M. Harvey, MD, MPH, FAAD | Skin of Color Society President (2022-2023) and Chair, Diversity in Dermatology Clinical Trials Task Force; Co-Director, Skin of Color Research Institute, Hampton University | ||
| SESSION 1: Understanding the Current Clinical Trials Landscape | (with Panel Q&A sessions) | ||
| 2:00 | 3:20 | Clinical Trials in Dermatology |
| Adam Friedman, MD, FAAD | Professor & Chair of Dermatology, Director, Residency Program; Director, Translational Research GW Medical Faculty Associates | ||
| Joel M. Gelfand, MD, MSCE, FAAD | James J. Leyden Professor of Dermatology and of Epidemiology; Vice Chair of Clinical Research and Medical Director, Dermatology Clinical Studies Unit; Director, Psoriasis and Phototherapy Treatment Center, University of Pennsylvania Perelman School of Medicine | ||
| Jonathan S. Weiss, MD, FAAD | Georgia Dermatology Partners | ||
| Panel Moderator: Valerie M. Harvey, MD, MPH, FAAD | Skin of Color Society President (2022-2023) and Chair, Diversity in Dermatology Clinical Trials Task Force; Co-Director, Skin of Color Research Institute, Hampton University | ||
| 3:20 | 3:30 | BREAK | Coffee & Tea |
| 3:32 | 4:52 | Clinical Trial Diversity – Perspectives from the FDA, NIH, and Dermatology |
| RADM Richardae Araojo | Associate Commissioner for Minority Health, FDA Office of Minority Health and Health Equity (OMHHE) | ||
| Leslie Castelo-Soccio, MD, PhD, FAAD | Staff Clinician; Dermatologist, Cutaneous Microbiome and Inflammation Laboratory; Attending Physician, Dermatology Consultation Service, National Institutes of Health | ||
| Arash Mostaghimi, MD, MPH, FAAD | Assistant Professor of Dermatology, Brigham & Women’s Hospital; Director, Inpatient Consultation Service, Department of Dermatology, Harvard University; Associate Editor, JAMA Dermatology | ||
| Keyvan Nouri, MD, MBA, FAAD | Professor of Dermatology, Ophthalmology, Otolaryngology and Surgery; Louis C. Skinner, Jr., M.D. Endowed Chair in Dermatology; Richard Helfman Professor of Dermatologic Surgery; Chair of the University of Miami Medical Group; Director of Mohs, Dermatologic & Laser Surgery; Director of Surgical Training; Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery; University of Miami Leonard M. Miller School of Medicine | ||
| Panel Moderator: Ginette A. Okoye, MD, FAAD | Professor of Dermatology, Department Chair, Howard University | ||
| 4:52 | 4:55 | Day 1 Closing Remarks |
| Valerie M. Harvey, MD, MPH, FAAD | Skin of Color Society President (2022-2023) and Chair, Diversity in Dermatology Clinical Trials Task Force; Co-Director, Skin of Color Research Institute, Hampton University | ||
| 6:00 | 8:00 | NETWORKING RECEPTION |
SATURDAY, JUNE 11, 2022
| Start (EDT) | End (EDT) | Session Details |
|---|---|---|
| 7:30 AM | 8:00 AM | BREAKFAST | Breakfast to be served. |
| 8:00 | 8:05 | Introduction |
| Valerie M. Harvey, MD, MPH, FAAD | Skin of Color Society President (2022-2023) and Chair, Diversity in Dermatology Clinical Trials Task Force; Co-Director, Skin of Color Research Institute, Hampton University | ||
| 8:05 | 8:50 | KEYNOTE SPEAKER | Historical Perspectives on Henrietta Lacks |
| Representatives from Henrietta Lacks Family (David Lacks, Jr. and Veronica Robinson) | ||
| Q&A moderated by Valerie M. Harvey, MD, MPH, FAAD | ||
| SESSION 2: Breaking Down Barriers: Patient, Provider, Industry, Regulatory | (with Panel Q&A sessions) | ||
| 8:52 | 9:42 | Patient-Related Barriers |
| Jocelyn M. Ashford | Head of Global Patient Advocacy, Cardiorenal, BridgeBio Pharma | ||
| Gretchen C. Wartman | Vice President for Policy and Program, National Minority Quality Forum | ||
| Panel Moderator: Tarannum Jaleel, MD | Duke University Medical Center Dermatology | ||
| 9:52 | 10:02 | BREAK | Coffee & Tea |
| 10:02 | 10:47 | Provider-Related Barriers |
| Cheryl Burgess, MD, FAAD | Founder and President, Center for Dermatology and Dermatologic Surgery | ||
| Jennifer T. Huang, MD, FAAD |Associate Professor of Dermatology, Harvard Medical School | ||
| Amy McMichael, MD, FAAD | Professor and Chair, Department of Dermatology, Wake Forest University School of Medicine | ||
| Neelam Vashi, MD, FAAD | Associate Professor of Dermatology, Boston University School of Medicine; Founder and Director, Center for Ethnic Skin; Director, Cosmetic and Laser Center | ||
| Panel Moderator: Valerie M. Harvey, MD, MPH, FAAD | Skin of Color Society President (2022-2023) and Chair, Diversity in Dermatology Clinical Trials Task Force; Co-Director, Skin of Color Research Institute, Hampton University | ||
| 10:48 | 11:48 | Industry & Regulatory Barriers |
| Angel S. Byrd, MD, PhD | Assistant Professor, Howard University College of Medicine; Adjunct Assistant Professor, JHUSOM (Department of Dermatology) | ||
| Kimberly Doggett | Head of Site Engagement, UCB | ||
| Rhonda Peebles, BS, MS | Head of Dermatology, UCB | ||
| Panel Moderator: TBD | ||
| 11:50 AM | 12:45 PM | LUNCH | Lunch to be served. |
| SESSION 3: Effecting Change through a Diversity-Focused Strategy | (with Panel Q&A sessions) | ||
| 12:47 | 1:47 | How to Create and Build Trust |
| Tesheia H. Johnson, MBA, MHS | Deputy Director COO YCCI Dir Clinical Research YSM; Chief Operating Officer, YCCI; Chief Officer and Deputy Director; Yale Center for Clinical Investigation; Yale Cultural Ambassadors Program | ||
| Fabian Sandoval, MD | CEO & Research Director; Emerson Clinical Research Institute, Inc. | ||
| Panel Moderator: Candrice R. Heath, MD, FAAD | Assistant Professor, Dermatology, Lewis Katz School of Medicine, Temple University | ||
| 1:49 | 2:49 | Imparting Ownership to Clinical Trial Participants: From Patients to Researchers |
| Allison Kalloo, MPH | Founder & President, Clinical Ambassador Holdings LLC & iParticipate, Inc. | ||
| James H. Powell, MD | Principal Investigator, National Medical Association, Project IMPACT; President, Strategic Medical Associates; Co-Founder, Chief Medical Officer, knowRx | ||
| Gretchen C. Wartman |Vice President for Policy and Program, National Minority Quality Forum | ||
| Panel Moderator: Angel S. Byrd, MD, PhD | Assistant Professor, Howard University College of Medicine; Adjunct Assistant Professor, JHUSOM (Department of Dermatology) | ||
| 2:49 | 2:59 | BREAK | Coffee & Tea |
| 3:01 | 4:31 | Industry Roundtable |
| Daphne Chan, PhD, MHEcon | Head of Dermatology Medical Affairs, The Janssen Pharmaceutical Companies of Johnson & Johnson | ||
| David Chu, MD, PhD | Executive Director, Clinical Development, Arcutis Biotherapeutics | ||
| Sharon Hanlon, MSN | Senior Director, Clinical Trial Engagement & Enrollment, Bristol-Myers Squibb | ||
| Lotus Mallbris, MD, PhD | Vice President of Lilly Immunology Development and Medical Affairs, Eli Lilly and Company | ||
| Chudy Nduaka, DVM, PhD, DABT | Therapeutic Area Head, Dermatology, AbbVie Medical Affairs, AbbVie | ||
| Rhonda Peebles, BS, MS | Head of Dermatology, UCB | ||
| Paul J. Rowe, MD, ATSF | Vice President, Head of Global Medical, Immunology – Specialty Care, Sanofi | ||
| Janet Wangari-Olivero, PhD | Director, Advanced Research; L’Oreal Research & Innovation | ||
| JP York, PhD | Associate Director, Prescription Medical Affairs, Galderma Laboratories LP | ||
| Alisar S. Zahr, PhD | Director of Research and Clinical Development, Revision Skincare® | ||
| Panel Moderator: Donald A. Glass, II, MD, PhD, FAAD | Immediate Past President, Skin of Color Society; Assistant Professor, Department of Dermatology, University of Texas Southwestern Medical Center | ||
| 4:33 | 5:18 | Striving for Diversity in Research Studies – Perspectives from Dermatology Journal Editors |
| Dirk M. Elston, MD, FAAD | Deputy Editor, JAAD; Professor and Chairman, Department of Dermatology & Dermatology Surgery, Medical University of South Carolina | ||
| Russell P. Hall, III, MD | J. Lamar Callaway Professor; Editor, JID Innovations; Department of Dermatology, Duke University Medical Center | ||
| Arash Mostaghimi, MD, MPH, FAAD | Assistant Professor of Dermatology, Brigham & Women’s Hospital; Director, Inpatient Consultation Service, Department of Dermatology, Harvard University; Associate Editor, JAMA Dermatology | ||
| Panel Moderator: TBD | ||
| 5:20 | 6:05 | Innovation in Clinical Trials |
| Sybol Anderson, PhD | Director, Diversity in Research Programs, National Medical Fellowships | ||
| Tesheia H. Johnson, MBA, MHS | Deputy Director COO YCCI Dir Clinical Research YSM; Chief Operating Officer, YCCI; Chief Officer and Deputy Director; Yale Center for Clinical Investigation; Yale Cultural Ambassadors Program | ||
| Fabian Sandoval, MD | CEO & Research Director; Emerson Clinical Research Institute, Inc. | ||
| Betsey Zbyszynski | Head of Clinical Operations, VIAL | ||
| Panel Moderator: TBD | ||
| 6:05 | 6:10 | Closing Remarks |
| Valerie M. Harvey, MD, MPH, FAAD | Skin of Color Society President (2022-2023) and Chair, Diversity in Dermatology Clinical Trials Task Force; Co-Director, Skin of Color Research Institute, Hampton University |
Registration is $125.00 USD for both days.
Registration for the SOCS Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials has closed. Meeting recordings will be available this summer via the SOCS Dermatology E-learning + Equity Platform – DEEP (https://deep.skinofcolorsociety.org/).
Background of Unmet Needs in Dermatology Clinical Trials
The United States population is becoming increasingly more diverse. By the year 2044 the US will achieve “majority minority” status. Studies show that across numerous medical disciplines, minorities have been underrepresented in clinical research trials. For example, while Hispanics account for 16% of the US population they comprise only 1% of the clinical trial research population. While this topic has been extensively studied in other medical disciplines such as rheumatology and oncology, there are only three dermatologic studies that have explored minority participation in clinical research. Harvey et al. found significant underreporting of race and ethnicity in pediatric atopic dermatitis clinical trials. Shaw et al. found differences in trust and exposure to research between African American and white parents attending a pediatric dermatology clinic. Lastly, a recent systematic review of randomized controlled trials for six common skin disorders between 2010 and 2015 revealed a low rate of racial reporting and lower than proportional representation of the Latinx and Hispanic population.
Sponsorship
Support from industry involved in clinical trials will ensure key stakeholder representation in the summit. Sponsored participation is by invitation only. If your company is incloved in dermatology clinical trials, and you wish to participate, please contact Kimberly Miller, Executive Director, at kmiller@skinofcolorsociety.org for more information.
Our Sponsors
The Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials is made possible with thanks to the support of the following sponsors:
CHAMPION
AbbVie | Janssen
ALLY
Bristol Myers Squibb | Eli Lilly, Inc.
PARTNER
Arcutis Biotherapeutics, Inc. | Dermavant | Galderma | Google, Inc. | Sanofi-Regeneron
FRIEND
L’Oreal Dermatological Beauty Brands | Revision Skincare | UCB | Vial
2021-2022 SOCS Diversity in Dermatology Clinical Trials Task Force
Valerie M. Harvey, MD, MPH, FAAD | Chair
Adewole S. Adamson, MD, MPP, FAAD
Angel S. Byrd, MD, PhD
Valerie Callender, MD, FAAD
Seemal R. Desai, MD, FAAD
Donald A. Glass II, MD, PhD, FAAD
Candrice R. Heath, MD, FAAD
Tarannum Jaleel, MD
Lynn J. McKinley-Grant, MD, FAAD
Ginette A. Okoye, MD, FAAD
Susan C. Taylor, MD, FAAD
Stafford Brown, III, MS
Caryn Cobb, BA
Valerie M. Harvey, MD, MPH, FAAD
President, Skin of Color Society (2022-2023) and Chair, Diversity in Dermatology Clinical Trials Task Force; Co-Director, Skin of Color Research Institute, Hampton University
Health and Safety Precautions
COVID-19 VACCINATION STATUS
Our first priority is the safety of all those attending the Summit. Summit attendees and guests are asked to be fully vaccinated against COVID-19. SOCS relies on attendees’ and guests’ attestations and does not independently verify vaccination status.
“Fully vaccinated” is defined by the CDC as of 1/10/22 as follows, “People who are fully vaccinated are those who received the second dose in a two-dose COVID-19 vaccine series or one dose of the J&J/Janssen COVID-19 vaccine.”
Attendees and guests must monitor their own health status and not attend the Meeting if symptomatic of COVID-19 in any way or if they believe they have been exposed to someone with COVID-19.
MASK POLICY
SOCS recommends that Summit attendees wear masks while in the meeting room, but this is not a mandatory requirement.
PURPOSE
The purpose of the SOCS Summit Resident Member Travel Grant is to enable dermatology residents to attend the SOCS Meeting the Challenge Summit: Diversity in Dermatology Clinical Trials (“SOCS Summit: DiDCT”) taking place in Washington, DC on June 10-11, 2022. Grants are intended for travel, room and board as needed to attend the meeting. Availability to attend both days is required for consideration.
The Diversity in Dermatology in Clinical Trials Task Force will only consider budgeted costs for travel, room, and board.
8 travel grant awards are available of up to $1,000 USD each.
- Entry Deadline: April 14, 2022, at 11:59AM CT
*The system will automatically prevent entry submission after the deadline. - Finalists announced: End of April
*An email will be sent to the awardees on or around April 27, 2022.
APPLICANT ELIGIBILITY
- This program is reserved to current Skin of Color Society Resident Members.
TRAVEL GRANT REQUIREMENTS FOR RECIPIENTS
- Lodging: Overnight accommodation must be booked via the SOCS provided room-block registration at The Mayflower Hotel in Washington, DC.
- Completion of short surveys (post-event).
- A one-page written report by the awardee summarizing the experience and what was learned is required after attending the Summit, for possible publication on the SOCS website, annual meeting report, and social media.
SUBMIT YOUR APPLICATION
- Go to https://skinofcolor.awardsplatform.com/
- Login or create a new user account
- Select ‘SOCS DiDCT Travel Grant’ from the dropdown menu under ‘Category’
- Complete all other initial required fields (i.e., Entrant, Title)
- Click ‘Save + Next’ to proceed to complete the application form.
Please note that extensions will not be granted for this opportunity.
4/15/22 Update: The application cycle for this travel grant has now closed.
MEET THE FACULTY
David Lacks, Jr. is the grandson of Henrietta Lacks and the son of David “Sonny” Lacks. David has a degree in computer information systems and has traveled around the United States and Canada setting up computer systems and labs for companies and educational institutions. He also lends his talent to the Lacks family’s website. David is honored to serve on the National Institutes of Health panel, where he reviews proposals from researchers seeking to use the HeLa genome in their research.
Veronica Robinson is Henrietta Lacks’ great-granddaughter. Veronica is a patient rights advocate who speaks on Henrietta Lacks’ legacy, their family’s experience in biomedical research, impact on participation, and ethics in this modern era of precision medicine. Veronica travels the country sharing the Lacks Family’s efforts to control their medical history and rebuild trust with the medical community, subjects she was honored to speak about in a 2018 TEDx Talk. Working with the National Institutes of Health, Veronica serves as both an All of US Ambassador, advocating for access to precision medicine; and a Lacks Family Representative on the HeLa Genome Data Access Working Group. As a mentor for Baltimore City Public Schools, Veronica is committed to empowering the next generation. Inspired by Henrietta’s story, Veronica is currently studying at Baltimore City Community College to become a registered nurse to help make certain all people can access equitable and high-quality health care.
SESSION 1: Understanding the Current Clinical Trials Landscape
Clinical Trials in Dermatology
Adam Friedman, MD, FAAD
Professor & Chair of Dermatology, Director, Residency Program; Director, Translational Research GW Medical Faculty Associates
Joel M. Gelfand, MD, MSCE, FAAD
James J. Leyden Professor of Dermatology and of Epidemiology; Vice Chair of Clinical Research and Medical Director, Dermatology Clinical Studies Unit; Director, Psoriasis and Phototherapy Treatment Center, University of Pennsylvania Perelman School of Medicine
Jonathan S. Weiss, MD, FAAD
Adjunct Clinical Professor of Dermatology, Emory University School of Medicine; Georgia Dermatology Partners
Clinical Trial Diversity – Perspectives from the FDA, NIH, and Dermatology
RDML Richardae Araojo, PharmD, MS
Associate Commissioner for Minority Health, FDA Office of Minority Health and Health Equity (OMHHE)
Leslie Castelo-Soccio, MD, PhD, FAAD
Staff Clinician; Dermatologist, Cutaneous Microbiome and Inflammation Laboratory; Attending Physician, Dermatology Consultation Service, National Institutes of Health
Arash Mostaghimi, MD, MPH, FAAD
Assistant Professor of Dermatology, Brigham & Women’s Hospital; Director, Inpatient Consultation Service, Department of Dermatology, Harvard University; Associate Editor, JAMA Dermatology
Keyvan Nouri, MD, MBA, FAAD
Professor of Dermatology, Ophthalmology, Otolaryngology and Surgery; Louis C. Skinner, Jr., M.D. Endowed Chair in Dermatology; Richard Helfman Professor of Dermatologic Surgery; Chair of the University of Miami Medical Group; Director of Mohs, Dermatologic & Laser Surgery; Director of Surgical Training; Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery; University of Miami Leonard M. Miller School of Medicine
SESSION 2: Breaking Down Barriers: Patient, Provider, Industry, Regulatory
Patient-Related Barriers
Jocelyn M. Ashford
Head of Global Patient Advocacy, Cardiorenal, BridgeBio Pharma
Gretchen C. Wartman
Vice President for Policy and Program, National Minority Quality Forum
Provider-Related Barriers
Cheryl Burgess, MD, FAAD
Founder and President, Center for Dermatology and Dermatologic Surgery
Jennifer T. Huang, MD, FAAD
Associate Professor of Dermatology,
Harvard Medical School
Amy McMichael, MD, FAAD
Professor and Chair, Department of Dermatology, Wake Forest University School of Medicine
Neelam Vashi, MD, FAAD
Associate Professor of Dermatology, Boston University School of Medicine; Founder and Director, Center for Ethnic Skin; Director, Cosmetic and Laser Center
Industry and Regulatory Related Barriers
Angel Byrd, BS, MD, PhD
Assistant Professor, Howard University College of Medicine; Adjunct Assistant Professor, JHUSOM (Department of Dermatology)
Kimberly Doggett
Head of Site Engagement, UCB
Rhonda Peebles, BS, MS
Head of Dermatology, UCB
SESSION 3: Effecting Change through a Diversity-Focused Strategy
How to Create and Build Trust
Tesheia H. Johnson, MBA, MHS
Deputy Director, Chief Operating Officer, Yale Center for Clinical Investigation (YCCI); Director for Clinical Research, Yale School of Medicine (YSM); Yale Cultural Ambassadors Program
Fabian Sandoval, MD
CEO & Research Director; Emerson Clinical Research Institute, Inc.
Imparting Ownership to Clinical Trial Participants: From Patients to Researchers
Allison Kalloo, MPH
Founder & President, Clinical Ambassador Holdings LLC & iParticipate, Inc.
James H. Powell, MD
Principal Investigator, National Medical Association, Project IMPACT; President, Strategic Medical Associates; Co-Founder, Chief Medical Officer, knowRx
Gretchen C. Wartman
Vice President for Policy and Program, National Minority Quality Forum
Industry Roundtable
Daphne Chan, PhD, MHEcon
Head of Dermatology Medical Affairs,
The Janssen Pharmaceutical Companies of
Johnson & Johnson
David Chu, MD, PhD, FAAD
Executive Director, Clinical Development
Arcutis Biotherapeutics, Inc.
Sharon Hanlon, MSN
Senior Director
Clinical Trial Engagement & Enrollment
Bristol-Myers Squibb
Lotus Mallbris, MD, PhD
Vice President of Lilly Immunology Development and
Medical Affairs
Eli Lilly and Company
Rhonda Peebles, BS, MS
Head of Dermatology
UCB
Paul J. Rowe, MD, ATSF
Vice President, Head of Global Medical
Immunology – Specialty Care
Sanofi
Janet Wangari-Olivero, PhD
Director, Advanced Research
L’Oreal Research & Innovation
JP York, PhD
Associate Director, Prescription Medical Affairs
Galderma Laboratories LP
Alisar S. Zahr, PhD
Director of Research and Clinical Development
Revision Skincare®
Striving for Diversity in Research Studies – Perspectives from Dermatology Journal Editors
Dirk M. Elston, MD, FAAD
Deputy Editor, JAAD; Professor and Chairman,
Department of Dermatology & Dermatology Surgery, Medical University of South Carolina
Russell P. Hall, III, MD
J. Lamar Callaway Professor; Editor, JID Innovations; Department of Dermatology, Duke University Medical Center
Arash Mostaghimi, MD, MPH, FAAD
Assistant Professor of Dermatology, Brigham & Women’s Hospital; Director, Inpatient Consultation Service, Department of Dermatology, Harvard University; Associate Editor, JAMA Dermatology
Innovation in Clinical Trials
Sybol Anderson, PhD
Director, Diversity in Research Programs, National Medical Fellowships
Tesheia H. Johnson, MBA, MHS
Deputy Director, Chief Operating Officer, Yale Center for Clinical Investigation (YCCI); Director for Clinical Research, Yale School of Medicine (YSM); Yale Cultural Ambassadors Program
Fabian Sandoval, MD
CEO & Research Director; Emerson Clinical Research Institute, Inc.
Betsey Zbyszynski
Head of Clinical Operations, VIAL
Session Moderators
Members of the Skin of Color Society Diversity in Dermatology Clinical Trials Task Force
Valerie M. Harvey, MD, MPH, FAAD
Skin of Color Society President (2022-2023) and Chair, Diversity in Dermatology Clinical Trials Task Force; Co-Director, Skin of Color Research Institute, Hampton University
Angel S. Byrd, MD, PhD
Assistant Professor, Howard University College of Medicine; Adjunct Assistant Professor, JHUSOM (Department of Dermatology)
Donald A. Glass, II, MD, PhD, FAAD
Immediate Past President, Skin of Color Society;
Assistant Professor, Department of Dermatology, University of Texas Southwestern Medical Center
Candrice R. Heath, MD, FAAD
Secretary/Treasurer, Skin of Color Society; Assistant Professor, Dermatology, Lewis Katz School of Medicine, Temple University
Tarannum Jaleel, MD
Assistant Professor of Dermatology, Duke Dermatology, Duke University School of Medicine
Ginette A. Okoye, MD, FAAD
Professor of Dermatology, Department Chair, Howard University
#SOCS2022 #MeetingtheChallenge #DiversityinDermatologyClinicalTrials #SkinofColorSociety
Facebook
Twitter
Instagram